Merkliste 
 1 Ergebnisse 
 
1

Brentuximab vedotin for recurrent Hodgkin lymphoma after al..:

Bazarbachi, A ; Boumendil, A ; Finel, H...
https://discovery.ucl.ac.uk/id/eprint/10090500/3/Peggs_BV%20post%20allo.pdf.  , 2019